Results for tag: "CART Related Neurotoxicity Drug"

The CART Related Neurotoxicity Drug market is a subset of the Central Nervous System Drugs market. It focuses on drugs that target the CART (Cocaine and Amphetamine Regulated Transcript) protein, which is involved in the regulation of dopamine and other neurotransmitters. These drugs are used to treat a variety of neurological disorders, including addiction, depression, and anxiety. CART Related Neurotoxicity Drugs are designed to reduce the risk of neurotoxicity associated with long-term use of certain drugs, such as cocaine and amphetamines. Some of the major companies in the CART Related Neurotoxicity Drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Johnson & Johnson. These companies are involved in the development and marketing of CART Related Neurotoxicity Drugs, as well as other Central Nervous System Drugs. Show Less Read more